Literature DB >> 27783398

Genome Editing Techniques and Their Therapeutic Applications.

M P Calos1.   

Abstract

Fueled by advances in the field of genetics, the methods available to edit DNA sequences in living cells have continued to develop steadily. These technologies directly impact the fields of gene and cell therapy, where changes in the DNA sequence of target cells offer a route to correct genetic diseases and manipulate disorders like cancer. We review here the expanding menu of genome editing techniques and how they are being applied to therapeutic targets. The methods encompass a myriad of approaches to modify the covalent structure of DNA, including the targeted creation of double-strand breaks that can catalyze genomic changes, as well as the use of retroviruses and transposons to mediate gene addition, recombinases for sequence-specific gene addition and deletion, and base repair for direct sequence changes. The continued growth of the exciting field of genome editing is opening new possibilities for therapeutic intervention.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27783398     DOI: 10.1002/cpt.542

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Process Improvement for Maximized Therapeutic Innovation Outcome.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2018-01       Impact factor: 6.875

2.  Health Care Evolves From Reactive to Proactive.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2019-01       Impact factor: 6.875

Review 3.  Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering.

Authors:  Tuhin Kumar Guha; Alvan Wai; Georg Hausner
Journal:  Comput Struct Biotechnol J       Date:  2017-01-12       Impact factor: 7.271

4.  Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease.

Authors:  Quang Vinh Phan; Jörg Contzen; Petra Seemann; Manfred Gossen
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 5.  Gene Therapy Leaves a Vicious Cycle.

Authors:  Reena Goswami; Gayatri Subramanian; Liliya Silayeva; Isabelle Newkirk; Deborah Doctor; Karan Chawla; Saurabh Chattopadhyay; Dhyan Chandra; Nageswararao Chilukuri; Venkaiah Betapudi
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

6.  Lymph nodes may be a source for immunetherapy in gastric cancer.

Authors:  Paula Baraúna Assumpção; Erika Couto Canelas; Aline Cruz Ramos; Ana Anaissi; João Felipe Acioli; Geraldo Ishak; Sidney Santos; Samia Demachki; Paulo Assumpção
Journal:  Oncotarget       Date:  2020-05-12

7.  CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells.

Authors:  Jonathan M Geisinger; Tim Stearns
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

8.  DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Julia Ma; Christophe Pichavant; Haley du Bois; Mital Bhakta; Michele P Calos
Journal:  Mol Ther Methods Clin Dev       Date:  2017-10-24       Impact factor: 6.698

9.  Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.

Authors:  Yanlin Wang; Lei Hao; Hongcai Wang; Katherine Santostefano; Arjun Thapa; John Cleary; Hui Li; Xiuming Guo; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2018-09-11       Impact factor: 11.454

10.  Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy.

Authors:  Tuhin K Guha; Christophe Pichavant; Michele P Calos
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-14       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.